This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McClure, S. J. Articles by Zaman, A. G. Search for Related Content PubMed Articles by McClure, S. J. Articles by Zaman, A. G.

Percutaneous Coronary Revascularization Reduces Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration in Stable Coronary Artery Disease

Samuel J. McClure, MBChB, MRCP^_*, Scott Gall, MBChB, MRCP^_*, Clyde B. Schechter, MA, MD, FACPM, Mark Kearney, MBChB, MRCP, MD^,1 and Azfar G. Zaman, BSc, MBChB, MD, FRCP^_*,,2,_*

^_* Department of Cardiology, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom
Department of Family and Social Medicine, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York
Department of Cardiovascular Science, Leeds University, Leeds, United Kingdom
Freeman Hospital and University of Newcastle, Newcastle-upon-Tyne, United Kingdom.

View larger version (35K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Graph of Change in NT-proBNP Levels Before and 8 Weeks After PCR NT-proBNP = N-terminal pro-B-type natriuretic peptide; PCR = percutaneous coronary revascularization.